Mount Sinai Beth Israel Is Recognized by 2020 HealthFirst Quality Incentive Program

Members of the pediatrics, nursing, and dedicated P4P teams, left to right: Merlyn Nesbitt, Marie Tejada, Kathryn Gariba Benjamin, Raquel Falesbork, and Damilola Fenwa. Not pictured: Desiree Chow, MD, Yazmin Guzman, Yahaira Tejeda, and Lititia Satpathy.

Each year the Mount Sinai Health System participates in HealthFirst’s Quality Incentive Program, which rewards top performers for achieving the highest overall quality among their peers in clinical care, preventive cancer screenings, and effective management of chronic illnesses.

Mount Sinai Beth Israel earned the distinction as a “Top Performing Hospital” and was the number one performer in the Medicare program from HealthFirst’s 2020 Quality Incentive Program.

“This recognition reflects the amazing work of so many people and departments including Adult Primary Care, Pediatrics, Radiology, Gastroenterology, Gynecology, Nursing, and our terrific Care Coordinators,” says Paul Zucker, Vice President of Ambulatory Operations at Mount Sinai Beth Israel.

He adds, “Most importantly it demonstrates our ability to provide extremely high quality and well-coordinated care to those who have entrusted us to partner in their journey to health and wellness. As 2020 tested both the depth of our resilience and the agility with which we could counter the challenges that COVID-19 presented, this recognition takes on a very special meaning. I’m very proud to be associated with this distinguished group.”

Mount Sinai West Opens New Unit to Improve the Experience of Patients After Giving Birth

The new rooms feature large, digital communication boards that enhance communication among patients and families and their care teams.

Mount Sinai West has opened a new unit specifically designed to enhance the overall experience for parents and their newborns. The new unit features 21 spacious rooms with sleeping accommodations for a partner, renovated bathrooms, modern fixtures, and digital communication boards.

“We focused on providing a soothing environment for parents and babies that is conducive to bonding as well as patient healing, and optimizing the way we care for our patients,” says Holly Loudon, MD, Site Chair for Obstetrics, Gynecology and Reproductive Health at Mount Sinai West. “The new unit was specifically designed to enhance communication between patients and their care teams and provide the best possible experience.”

For example, new digital communication boards are used to improve patient and provider collaboration. The boards automatically pull key information from the patient’s medical record like names and photos of the care team.

They also display goals that the patient has identified, such as breastfeeding; goals for the baby, such as status of screenings and blood tests; and care team goals, such as progress on walking. A special touch screen section of the board allows patients, family members or others to write questions or updates. The screen serves as a reminder to both the family and the care team to address important items.

The new unit is just the latest in a number of improvements at Mount Sinai West, which has a culture that prioritizes low-intervention births and shared decision-making between providers and their pregnant patients and has a longstanding tradition of using midwives.

“We expect to have more than 4,000 births this year, so having an environment that reflects the high quality of care and service we have always provided is important,” says Evan Flatow, MD, President at Mount Sinai West, who led a recent ribbon-cutting ceremony at the new unit, known as 11A. “The new  unit is among several projects to improve the full range of care for new parents and babies, including a new neonatal intensive care unit (NICU) that opened in 2019 and improvements to the labor and delivery unit.”

Mount Sinai West was included on the inaugural list of high-performing Maternity Care hospitals released recently by U.S. News & World Report. Mount Sinai West, along with Mount Sinai Morningside, which are ranked together, are among 237 of 2,700 hospitals in the United States to this achieve this rating.

The official opening of 11A was celebrated by Mount Sinai West and Maternal Child Health leadership, physicians, and staff, from left to right: Erin Figueroa, MSN, RN NE-BC, Senior Director Nursing, Obstetrics and Gynecology; Evan Flatow, MD, President, Mount Sinai West; Holly Loudon, MD, MPH, Site Chair, Obstetrics and Gynecology; Linda Valentino, MSN, RN, NEA-BC, Chief Nursing Officer, Tim Day, Chief Operating Officer, and Cheryl Seredy, Marketing and Communications.

What to Do If You Test Positive for COVID-19

With the rise of the highly contagious Omicron variant, more and more people are testing positive for COVID-19, even those who have diligently taken all precautions throughout the pandemic.

There’s not necessarily cause for alarm. The Omicron variant, though far more contagious than earlier strains, appears to produce less serious symptoms, especially if you have been vaccinated and received a booster.

If you have just tested positive and are wondering about next steps, here are answers to some of the questions that Mount Sinai experts are fielding right now.

How should I care for myself?

You should rest, stay hydrated, and treat your symptoms with medications for fevers, cough, and other cold symptoms. For more information about how you can take care of yourself at home, read this article from Abigail R. Chen, MD, Senior Medical Director at Mount Sinai Doctors Downtown.

What does it mean to self-isolate?

  • Self-isolating requires staying away from other people. Stay home unless you need medical care.
  • Do not go to work, school, or public areas. Do not use public transportation, ride sharing, or taxis.
  • If possible, stay in one room, away from others in your home, and use a separate bathroom.
  • Practice basic hand hygiene.
  • Avoid sharing personal household items, such as dishes, towels, and bedding. Wash these items after using them.
  • Clean “high touch” surfaces daily. These may include counters, doorknobs, bathroom items, and phones. Clean any surfaces that may have blood, stool, or other bodily fluids on them.

Be especially careful if there are older adults in your home, or anyone with serious medical issues. These people may become more seriously ill from this infection. Do not handle pets or other animals while sick.

What should I tell my close contacts?

Anyone who has had close contact with you should call their doctor if they develop symptoms that may be caused by COVID-19. Symptoms may include sort throat, runny nose/nasal congestion, headache, fever, cough, or shortness of breath.

When can I stop self-isolating?

You can stop self-isolating after these three things have happened:

  1. You have not had a fever (your temperature has been less than 100.0° Fahrenheit or 38.0° Celsius) consistently for at least three days (72 hours) without taking fever reducing medications, such as aspirin or acetaminophen (Tylenol).
  2. Your breathing is improving.
  3. The recommended duration for isolation after testing positive for COVID-19 is constantly evolving. Staying at home for at least 10 days is the safest option for everyone. If you cannot stay home for 10 days, you may start going out on day 6 if you are fever-free for 24 hours, but you must wear a mask constantly when around other people until the 10 days are up. You should avoid travel and going to public places where you or others have to take off their masks, like restaurants, until the 10 days are up. If you are an essential worker, there are recommendations from the New York State Department of Health that will guide you on how to return to work safely in 5 days.

When should I call my doctor? 

Call your doctor if you start to feel worse, such as experiencing increased congestion, coughing, chest pain, or fever. For Mount Sinai doctors, most follow-up visits can be scheduled as a video visit or over the phone. For a video visit, you must have a MyChart account.

Seek emergency medical treatment if you have difficulty breathing; if possible, call ahead to let them know you may have COVID-19. If you call for emergency assistance to get you, put on a face mask before emergency medical services arrive.

Eight Key Takeaways About the Omicron Variant

With so much news about the Omicron variant, it can be hard to keep track of the latest developments. So here are eight key takeaways from the experts at Mount Sinai.

 

  1. Booster Shots are Crucial Protect yourself and those around you with the vaccines. If you have already received the initial round of vaccine shots, get the booster shot as soon as you are eligible. You can make an appointment here.
  • If you got the two-dose Pfizer-BioNTech vaccine, you can get the booster five months after your second shot. If you got the two-dose Moderna vaccine, you can get the booster five months after your second shot. You can get either the Pfizer or Moderna booster shot, whichever is available.
  • If you received the Johnson & Johnson vaccine, you should get a booster shot two months after your shot. You can get any of the three vaccines for the booster; health authorities recommend getting the Pfizer or Moderna vaccine for your booster.
  1. Severe Disease in Unvaccinated People  The available data continues to indicate the Omicron variant causes less severe symptoms than the Delta variant. Note that a lot of the data available on the Omicron variant causing less severe symptoms is in the setting where the majority of the people being exposed are fully vaccinated. The Omicron variant can still lead to severe disease in unvaccinated people. Many fully vaccinated people infected with the Omicron variant experience little or no symptoms, often similar to the common cold. That’s one reason why the Centers for Disease Control and Prevention recently eased the guidelines on self-quarantining. But those who are infected still pose a risk of spreading the infection to others who may be immunocompromised, such as older adults and those with some serious illnesses, who are at greater risk of serious illness from COVID-19.
  1. Keep Up With Safety Steps  Getting vaccinated and a booster will keep you from getting a serious illness. But being vaccinated will not keep you from spreading the infection to others, especially if you have no symptoms while you are contagious. That is why we need to keep doing what we have been doing—wearing masks in indoor public settings, practicing social distancing, and avoiding large gatherings. And if you are experiencing any symptoms, please stay home.
  1. Omicron Variant Spreading Rapidly Since it was first detected in the United States, the Omicron variant has spread rapidly in the New York metropolitan area and throughout the country, with COVID-19 cases surpassing the peak of daily reported cases of the earlier surge over the summer. The positivity rate in New York City (the percent of people tested who are positive, not including most home tests) is at record levels. Fortunately, thanks to the New York region’s high vaccination rates, almost all infections are mild to moderate in severity and do not require hospitalization.
  1. Omicron Variant More Contagious The Omicron variant is more contagious than the Delta variant because of the many mutations that have occurred, which makes the virus harder for your previously formed antibodies to bind and neutralize it. As a result, the Omicron variant is surpassing the Delta variant as the dominant strain, much as the Delta variant surpassed the Gamma, Beta, and Alpha variants that came before it.
  1. Antiviral Treatments  Promising, But Not Widely Available While doctors have learned much about COVID-19, there are no widely available, effective treatments for the infection that results from the Omicron variant. Most of the monoclonal antibodies, which had shown promise for earlier variants, are not considered effective for the Omicron variant. The U.S. Food and Drug Administration recently authorized the first pills for treatment of the virus, Pfizer’s Paxlovid and Merck’s molnupiravir. The pills are only authorized for treatment of those who are at high risk for progression to severe COVID-19, including hospitalization or death. These treatments are not yet widely available and will be reserved for a limited number of patients most at risk for developing serious disease.
  1. More Children Are Getting COVID-19 Mount Sinai is seeing an increase in children with COVID-19 at Mount Sinai Kravis Children’s Hospital and in our Emergency Department. Many are either not vaccinated or not eligible for vaccination. Severe COVID-19 infections among children remain uncommon. Our pediatric vaccination pods are open and accepting patient appointments, and we highly encourage parents to have eligible children vaccinated. You can make an appointment for a first dose here and for a booster here.
  1. Cause for Optimism  There remain many reasons for optimism. Our medical community has the resources and experience to care for those who are in need of treatment for COVID-19 or other medical conditions. Mount Sinai, for example, continues to follow strict protocols to maintain the safety of patients, employees, and the community, as it has throughout the pandemic. In South Africa, where the Omicron variant was first detected, there are reports that the number of cases has begun to fall off significantly.

Mount Sinai Doctors Medicine Multispecialty Offers Collaborative Care in a New Space at Mount Sinai Morningside

Left to right: Javier Zulueta, MD, Rahul Agarwal, MD, and Fernando Carnavali, MD 

A new practice specifically addressing the needs of ambulatory patients has opened in the Ambulatory Care Center at Mount Sinai Morningside.

Mount Sinai Doctors Medicine Multispecialty offers a wide range of specialty care that allows an integrative team approach for chronic disease management and several new programs where specialists collaborate on patient care. Many patients benefit from having all of their sub-specialists in one office where physicians work together to improve patients’ health. The practice is located at 440 W. 114 Street, Sixth Floor.

“What’s different here from the way we provided care to our patients in the past is we have experts across many specialties caring for patients all in the same place,” says Arthur A. Gianelli, FACHE, President, Mount Sinai Morningside. “We think this is a wonderful opportunity to provide collaborative care to our patients because we know nothing is simple about getting multiple physicians to coordinate your care.”

He adds, “We can provide care for any stage of life, compassionate care for you and your family, your loved ones, right here in the community.”

There are seven subspecialties in the new practice: Allergy and Immunology, Endocrinology, Diabetes and Bone Diseases/Weight Management, Infectious Diseases, Gastroenterology, Pulmonology, Nephrology, and Rheumatology.

In addition, there are four new programs:

Travel Medicine works with patients on the prevention and management of health problems associated with travel. The physicians at Mount Sinai Morningside are board certified in infectious diseases and experts in destination-specific health risks and preventative measures. These specialists address travelers’ vaccination requirements, and answer questions and make recommendations regarding disease exposure.

Venous Thromboembolism (VTE) utilizes a multidisciplinary approach to manage VTE by working closely and cross referring to colleagues in cardiology and cardiothoracic surgery. The team provides follow-up care to patients who were discharged from the hospital or Emergency Department to determine the cause of VTE, evaluates the duration, risks, and benefits of anticoagulation therapy, and works to avoid the development of Chronic Thromboembolic Pulmonary Hypertension as a complication of acute pulmonary embolism.

Lung Nodule(s) is an extension of the Lung Cancer Screening program at Mount Sinai Morningside. It will serve as a referral clinic for all patients who have a lung nodule(s) detected on computed tomography (CT) scans either incidentally or as part of a screening program. Following specific protocols for follow-up and diagnosis of nodules avoids unnecessary invasive procedures while maximizing the diagnosis of lung cancer in its earliest stage when it is most treatable.

Fracture Reduction is a joint effort of Endocrinology and Rheumatology to screen for osteoporosis in individuals over the age of 50 to reduce non-traumatic fractures. A large number of patients hospitalized with hip and other non-traumatic fractures will benefit from biochemical and bone density scan (DXA) evaluation to screen for and treat osteoporosis and reduce the risk of a subsequent fracture and other medical conditions that are caused by or made worse by fractures.

To make an appointment with the Medicine Multispecialty practice, call 212-523-8672.

Transformational Gift Supports Obstetrics, Gynecology, and Reproductive Science at Mount Sinai

Raquel and Jaime Gilinski

Raquel and Jaime Gilinski

In visionary support for women’s health, the Mount Sinai Health System has received a multimillion-dollar commitment from Raquel and Jaime Gilinski for the Department of Obstetrics, Gynecology, and Reproductive Science at The Mount Sinai Hospital.

The gift is being given in honor of Michael Brodman, MD, who for 19 years has served with distinction as the Ellen and Howard C. Katz Chairman’s Chair in Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai.  Mrs. Gilinski, who serves on the Board of Trustees at Mount Sinai, and her family, have an enduring history of philanthropic support around women’s health at Mount Sinai under Dr. Brodman’s leadership.

“I am honored and thankful to Raquel and Jaime for their ongoing support and advocacy for women’s health at Mount Sinai,” Dr. Brodman says.  “This gift will ensure that we continue to offer women and their families excellent care in a modern and comfortable environment”.

Oversight and implementation of the gift will be managed by Joanne L. Stone, MD, Director of the Maternal Fetal Medicine and Fellowship program for the Mount Sinai Health System, Vice Chair for Diversity and Inclusion of the OB/GYN Department, and immediate past President of the Faculty Council.  Dr. Stone, a world-renowned physician-scientist with special expertise in women’s health and fetal imaging, will succeed Dr. Brodman as Chair effective January 1, 2022.

“We are ever so grateful for the tremendous gift that the Gilinskis have made to champion women’s health at Mount Sinai. Their visionary support will allow us to build upon Mount Sinai’s legacy of providing comprehensive care, research, and advocacy to women for generations to come,” says Dr. Stone.

This generous gift will establish the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai.  The new gift will support capital projects and renovations to elevate care and services in women’s health at The Mount Sinai Hospital.

“As the torch of leadership is passed from Dr. Brodman to Dr. Stone, we remain committed to the outstanding work of Mount Sinai in the field of Obstetrics and Gynecology that will ultimately lead to more comprehensive care and positive outcomes for women,” says Mrs. Gilinski.

Pin It on Pinterest